Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)
Clinical trial NCT01242514 · TERMINATED
Trial details
- NCT number
- NCT01242514
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2015-01-01
- Enrollment
- 1917
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.